. LaunayO, ChemlalK, AndrieuV, CarbonC. Severe reversible reticulo-cytopenic anemia associated with quinupristin/dalfopristin RP59500 therapy. Clin Infect Dis1997; 25: 156.
2.
. Physicians' desk reference. Montvale, NJ: Medical Economics, 2003: 769–73.
3.
. NaranjoCA, BustoU, SellersEM, SandorP, RuizI, RobertsEA, A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
